Literature DB >> 19581526

Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.

Richard L Schilsky1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581526     DOI: 10.1200/JCO.2009.24.6827

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Muscle depletion and the prediction of chemotherapy toxicity.

Authors:  Maurizio Muscaritoli; Alessio Molfino; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2013-06-11       Impact factor: 3.397

2.  Clinical trials in the era of personalized oncology.

Authors:  Michael L Maitland; Richard L Schilsky
Journal:  CA Cancer J Clin       Date:  2011-10-27       Impact factor: 508.702

Review 3.  Survivors of breast cancer: patient perspectives on survivorship care planning.

Authors:  Sally L Smith; Savitri Singh-Carlson; Lindsay Downie; Nancy Payeur; Elaine S Wai
Journal:  J Cancer Surviv       Date:  2011-06-04       Impact factor: 4.442

Review 4.  Biomarker validation and testing.

Authors:  Daniel F Hayes
Journal:  Mol Oncol       Date:  2014-10-18       Impact factor: 6.603

Review 5.  Personalized colon cancer care in 2010.

Authors:  Daniel V T Catenacci; Mark Kozloff; Hedy L Kindler; Blase Polite
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

6.  Phase III clinical trial development: a process of chutes and ladders.

Authors:  David M Dilts; Steven K Cheng; Joshua S Crites; Alan B Sandler; James H Doroshow
Journal:  Clin Cancer Res       Date:  2010-11-09       Impact factor: 12.531

Review 7.  Publication of tumor marker research results: the necessity for complete and transparent reporting.

Authors:  Lisa M McShane; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

8.  Statistical challenges in the development and evaluation of marker-based clinical tests.

Authors:  Lisa M McShane
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

9.  Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine.

Authors:  I-Chien Wu; Cheng-Chieh Lin; Chao A Hsiung
Journal:  Biomedicine (Taipei)       Date:  2015-02-02

10.  OMICS-based personalized oncology: if it is worth doing, it is worth doing well!

Authors:  Daniel F Hayes
Journal:  BMC Med       Date:  2013-10-17       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.